Капреоцин (Капреоміцин)

Основна інформація

• Доступно на:
• English
• Український

Claribaccin is a product that contains the active ingredient clarithromycin, a semisynthetic macrolide antibiotic. Clarithromycin is derived from erythromycin through the substitution of the CN3O hydroxyl group with an (OH) group at the 6th position of the lactone ring. This modification results in the formation of 6-Omethylerythromycin A, which is the key component of Claribaccin.

The main mode of action of clarithromycin is its binding to the 50S ribosomal subunit of susceptible bacteria. By doing so, it prevents the translocation of activated amino acids, inhibiting the intracellular protein synthesis of the microorganisms that are sensitive to clarithromycin. This disruption of protein synthesis is what ultimately enables clarithromycin to exert its potent antibacterial effects.

Clarithromycin is widely recognized for its effectiveness in treating various bacterial infections. Its ability to inhibit protein synthesis in sensitive microorganisms makes it an invaluable tool in combating bacterial diseases. Whether it is respiratory tract infections, skin and soft tissue infections, or even Helicobacter pylori-associated peptic ulcers, Claribaccin can be an effective solution in the fight against these bacterial ailments.

With its broad spectrum of activity and favorable pharmacokinetic properties, Claribaccin has become a trusted choice in the medical field. Its ability to target and halt intracellular protein synthesis sets it apart in the treatment of susceptible bacterial infections, making it a valuable asset in the pharmaceutical industry.